Granite Bay Wealth Management, LLC Bio N Tech Se Transaction History

Granite Bay Wealth Management, LLC

  • $178 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024
BUY
$80.36 - $102.87 $1.48 Million - $1.9 Million
18,459 New
18,459 $1.69 Million
Q4 2023

Jan 29, 2024
SELL
$90.91 - $112.75 $233,093 - $289,091
-2,564 Reduced 12.6%
17,778 $1.79 Million
Q3 2023

Oct 12, 2023
BUY
$98.5 - $125.08 $2 Million - $2.54 Million
20,342 New
20,342 $2.25 Million

Others Institutions Holding BNTX

# of Institutions
357
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Granite Bay Wealth Management, LLC Portfolio

Follow Granite Bay Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Bay Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Bay Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email